Wang & Lung [61] demonstrated that both APOE ε4 and PGC-1α polymorphisms increase insomnia risk, and that the effect of PGC-1α remains even after controlling for APOE ε4 status. The gene discussed is PPARGC1A; the disease is insomnia.